TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients
Clinical trial NCT01202825 · COMPLETED
Trial details
- NCT number
- NCT01202825
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-11-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.